Andrew Pitts - Aug 10, 2021

A new referral to the EPO’s Enlarged Board of Appeal is plausible

Despite not having any express legislative basis in the European..

Daniel Yin - Jul 28, 2021

Senolytics are knock, knock, knocking on ageing’s door

In 1974, Bob Dylan asked that we stay forever young. Today, exciting..

Fay Allen - Jul 28, 2021

Is metformin the key to anti-aging?

By 2050, it is estimated that one quarter of the global population..

Niles Beadman - Jul 20, 2021

Printed pills: a new dimension for medicine

Three dimensional (3D) printing is the latest buzzword ricocheting..

Rebecca Anderson-Smith - Jul 06, 2021

Non-traditional pharma trade marks: position marks

In this final blog in our non-traditional pharma trade mark series,..

Jo Cripps - Jun 08, 2021

Need to Know: why your virome holds enormous value

Our bodies play host to a complex network of viruses, many of which..

Samuel Hart - Jun 03, 2021

Healthy eating means more than just a balanced diet: future foods and fighting the risk of infection

Human health is inextricably linked to food – not least because..

Genevieve Pugh - Jun 01, 2021

Delivering drugs with DNA

We explore the emerging field of DNA and RNA nanotechnology, its..

Rebecca Anderson-Smith - May 27, 2021

Non-traditional pharma trade marks: sound, motion and multimedia marks

Following on from our previous blog posts examining the role of shape..

Patent Settlement Agreements with a “Pay for Delay” element – restrictive ‘by object’?

Almost two decades ago the European Commission (EC) launched a..

Joseph Newcombe - Apr 26, 2021

COVID-19 win for AI pharma farmers

The vaccine roll-out is in action all over the world. Nevertheless,..

Adam Gregory - Apr 19, 2021

Jim Mellon: the reluctant gradualist taking on ageing

Forward editor Caitlin Mackesy Davies learns how we might all be able..

Sarah Harvey - Mar 23, 2021

EPO 2020 Patent Index - key trends

The European Patent Office (EPO) recently published its 2020 Patent..

Rebecca Anderson-Smith - Mar 22, 2021

Pharma brands: what's in a name?

Pinning down a new drug name that will both catch attention and clear..

Eleanor Maciver - Mar 12, 2021

Selection inventions before the EPO

Chemical inventions are subject to the same criteria as all..

Robert Watson - Feb 05, 2021

Out of Oz: the remarkable life and times of AMP945

Bringing a new cancer treatment to the public can be a complex..

Eliot Ward - Dec 21, 2020

Will the COVID-19 vaccines induce more robust immunity than infection with SARS-Cov-2 itself?

Respiratory viruses such as coronaviruses are notorious for evading..

Nick Sutcliffe - Nov 25, 2020

AstraZeneca/Oxford University vaccine shows efficacy against SARS-CoV-2

AstraZeneca/Oxford University have announced that their SARS-CoV-2..

Nick Sutcliffe - Nov 16, 2020

And then there were two – Moderna SARS-CoV-2 vaccine shows efficacy

Moderna have announced that their SARS-CoV-2 vaccine candidate..

Joseph Newcombe - Oct 29, 2020

Personalising medicine based on gut reaction

No, we are not talking about jumping to conclusions, but the..

Rebecca Anderson-Smith - Oct 28, 2020

Naming pharmaceuticals: considerations for choosing, clearing and registering pharmaceutical brand names

There are many different types of names you might see associated with..

Melodie Richardson - Sep 04, 2020

Combatting COVID-19: does Vitamin D have a role to play?

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), better..

Jane Liu - Sep 02, 2020

The emergence of liquid biopsies as companion diagnostics

The development of liquid biopsies

The term liquid biopsy refers to..

Joseph Newcombe - Sep 02, 2020

Polymorphism: crystal clear or murky water

Movers and shapeshifters in the world of solid state chemistry

Have..

Eleanor Maciver - Aug 28, 2020

Antimicrobial resistance – a global response to a global threat

The discovery and development of antimicrobial agents and..

James Leach - Aug 10, 2020

Antimicrobial resistance: moving towards a targeted approach

Spectromics is working to put our existing arsenal of antibiotics to..

Sarah Kostiuk-Smith - Jul 05, 2020

Medicine's most wanted

Will the world's most dangerous microbes soon meet their match?..

Helen Bower - Jun 19, 2020

Financial Times: Europe's Leading Patent Law Firms 2020

We are delighted to once again be recognised in the Financial Times’..

Joseph Newcombe - Jun 12, 2020

Hot Chemistry – Shining a light on disease with radiopharmaceuticals

Back in 1979 The Buggles sang “video killed the radio star”. However,..

Sarah Kostiuk-Smith - Jun 01, 2020

Is faster drug development likely to become the “new normal?”

As part of our Thought Leaders series, Mewburn Ellis Partner Sarah..

Richard Clegg - May 14, 2020

Singapore's biotech breakthrough

From the far east to the east coast of America, the world is taking..

Rhiannon Wescott - May 01, 2020

Can a functionally defined patent claim ‘protect’ my medicinal product?

From a patent perspective this may seem like a strange question with..

Robert Andrews - Apr 30, 2020

BerGenBio’s bemcentinib selected for fast track as potential treatment for coronavirus (COVID-19)

In the fight against the coronavirus pandemic, bemcentinib produced..

Sarah Kostiuk-Smith - Apr 20, 2020

Has a cure for coronavirus (COVID-19) already been made?

Faced with the biggest global pandemic in most of our lifetimes, all..

Andrew Tindall - Mar 24, 2020

Coronavirus (COVID-19): a case study in emerging disease

Update: This article was updated on 24 March 2020 to reflect new..

Rebecca Anderson-Smith - Mar 19, 2020

Parallel imports of pharmaceuticals – A UK trade mark perspective

The UK parallel import licensing scheme lets a medicine authorised in..

Sarah Kostiuk-Smith - Feb 21, 2020

2020 BioInfect Conference - tackling antimicrobial resistance

Antimicrobial resistance (AMR) poses a global threat.  No new classes..

Thomas Driver - Feb 06, 2020

Genetic engineering and synthetic biology – making cannabis production greener

The therapeutic benefits of medicinal cannabis have been liberally..

Jane Liu - Jan 23, 2020

A promising target for new antibiotics

In previous blogs we have discussed the global threat of ..

Callum McGuinn - Nov 12, 2019

Using IP to secure opportunities in the budding medical cannabis sector

The opportunities for innovation in medical cannabis dovetails with..

Sarah Kostiuk-Smith - Sep 27, 2019

AMR - a global threat

A hot topic on everyone’s lips at the moment is Climate Change and..

Callum McGuinn - Sep 26, 2019

Budding opportunities for pharma

With shifting attitudes surrounding cannabis-based drugs, it is..

Joseph Newcombe - Sep 25, 2019

From data to drugs - a brief introduction to AI in drug discovery

The road to an approved drug is well known to be an arduous journey...

Callum McGuinn - Sep 17, 2019

Cannabis: on to greener pastures?

Callum McGuinn, explores the history of social attitudes towards..

Callum McGuinn - Jun 18, 2019

Medicinal cannabis: recent changes and future innovations

Government policy on the prescription of cannabis-derived medicines..

Julie Carlisle - Mar 28, 2019

Dosage regimen patents: bruised but not beaten

Ruling on the big pharma Actavis v ICOS case, the UK Supreme Court..

Sean Jauss - Jan 14, 2019

Eight key themes from the J.P. Morgan Healthcare Conference

I’ve spent the last few days talking with biotech entrepreneurs, VC..

Richard Clegg - Dec 10, 2018

Clovis Oncology success in European Opposition Proceedings related to Rubraca®

Clovis Oncology has announced that the European Patent Office (EPO)..

Anna Mudge - Dec 02, 2018

The importance of Innovation Hubs in the UK's North West Region

Life science ‘start-ups’, ‘spin-outs’ and SMEs are some of the most..

Nick Sutcliffe - Nov 14, 2018

Supreme Court decision signals bad news for patent holders

The UK Supreme Court issued its decision today on the Warner Lambert..

Matthew Smith - Oct 29, 2018

Development in the war on superbugs

The spread of antibiotic-resistant infections is one of the most..

Ashley Cresswell - Aug 01, 2017

UK Supreme Court Establishes Doctrine of Equivalents in Actavis v Lilly

In many jurisdictions a product or process may be held to infringe..